NATIONAL INSTITUTES OF HEALTH has floated a tender for Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed). The project location is USA and the tender is closing on 07 May 2021. The tender notice number is PA-18-678, while the TOT Ref Number is 20949244. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)

Deadline : 07 May 2021

Other Information

Notice Type : Tender

TOT Ref.No.: 20949244

Document Ref. No. : PA-18-678

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
USA
Email :FBOWebmaster@OD.NIH.GOV

Tender Details

Tender are invited for Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)

CFDA Number : 93.393 -- Cancer Cause and Prevention Research

Cost Sharing or Matching Requirement : No

Closing Date for Applications: May 07, 2021

Posted Date : Feb 23, 2018

Description: The purpose of this concept initiative is to promote etiologic research investigating novel and innovative hypotheses on emerging risk factors (biological, environmental, and social) and their interplay with established risk factors (e.g., viral hepatitis) associated with the development of liver cancer (hepatocellular carcinoma and other histological subtypes) in the United States.

Documents

 Tender Notice